J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India · Delayed Price · Currency is INR 1,892.70
-12.05 (-0.63%)
At close: Feb 13, 2026
BOM:506943 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 6,596 | 5,526 | 4,098 | 3,854 | 4,480 |
Depreciation & Amortization | 1,702 | 1,377 | 1,120 | 722.41 | 683.27 |
Other Amortization | 7.97 | 6.28 | - | 4.19 | 3.38 |
Loss (Gain) From Sale of Assets | -2.12 | 2.32 | 0.4 | -24.05 | -524.37 |
Loss (Gain) From Sale of Investments | -322.08 | -327.43 | -69 | -350.43 | -505.5 |
Stock-Based Compensation | 549.03 | 419.67 | 669.02 | 626.54 | - |
Provision & Write-off of Bad Debts | 42.91 | 114.01 | 30.71 | - | 7.96 |
Other Operating Activities | 378.84 | 944.43 | 563.2 | -106.65 | -54.45 |
Change in Accounts Receivable | -498 | -716.04 | -194.92 | -2,928 | -705.99 |
Change in Inventory | -264.42 | -720.29 | -371.67 | -625.14 | -700.86 |
Change in Accounts Payable | 834.16 | 1,380 | 440.44 | 529.3 | 464.75 |
Operating Cash Flow | 9,024 | 8,006 | 6,286 | 1,701 | 3,148 |
Operating Cash Flow Growth | 12.72% | 27.36% | 269.50% | -45.95% | 14.16% |
Capital Expenditures | -975.88 | -1,269 | -724.61 | -628.7 | -477.73 |
Sale of Property, Plant & Equipment | 11.14 | 9.77 | 7.72 | 77.75 | 483.89 |
Cash Acquisitions | - | - | - | - | -85 |
Sale (Purchase) of Intangibles | -227.19 | -1,345 | -6,853 | -6,439 | - |
Investment in Securities | 754.79 | -1,496 | -1,863 | 7,002 | -2,241 |
Other Investing Activities | -2,522 | 62.07 | -125.78 | 11.29 | 12.74 |
Investing Cash Flow | -2,959 | -4,038 | -9,559 | 23.2 | -2,307 |
Short-Term Debt Issued | - | - | - | - | 3.22 |
Long-Term Debt Issued | - | - | 6,086 | - | - |
Total Debt Issued | - | - | 6,086 | - | 3.22 |
Short-Term Debt Repaid | -3,439 | -125.96 | -195.25 | -3.27 | - |
Long-Term Debt Repaid | -131 | -1,917 | -956.86 | -80.38 | -81.56 |
Total Debt Repaid | -3,570 | -2,043 | -1,152 | -83.65 | -81.56 |
Net Debt Issued (Repaid) | -3,570 | -2,043 | 4,934 | -83.65 | -78.34 |
Issuance of Common Stock | 240.03 | 199.91 | 84.83 | - | - |
Common Dividends Paid | -2,370 | -1,570 | -1,276 | -1,276 | -732.4 |
Other Financing Activities | -96.16 | -442.13 | -308.98 | -24.57 | -63.49 |
Financing Cash Flow | -5,797 | -3,855 | 3,434 | -1,384 | -874.23 |
Foreign Exchange Rate Adjustments | -0.08 | -0.16 | 0.29 | 0.01 | 0.36 |
Net Cash Flow | 268.76 | 112.81 | 161.96 | 340.7 | -32.78 |
Free Cash Flow | 8,049 | 6,737 | 5,562 | 1,073 | 2,670 |
Free Cash Flow Growth | 19.46% | 21.14% | 418.51% | -59.83% | 31.68% |
Free Cash Flow Margin | 20.54% | 19.34% | 17.66% | 4.42% | 13.07% |
Free Cash Flow Per Share | 50.72 | 42.48 | 35.51 | 6.93 | 17.27 |
Cash Interest Paid | 96.16 | 442.13 | 308.98 | 24.57 | 63.49 |
Cash Income Tax Paid | 2,007 | 1,325 | 885.94 | 1,346 | 1,417 |
Levered Free Cash Flow | 6,445 | 3,716 | -2,598 | -5,711 | 2,006 |
Unlevered Free Cash Flow | 6,512 | 3,988 | -2,380 | -5,685 | 2,048 |
Change in Working Capital | 71.74 | -56.36 | -126.16 | -3,024 | -942.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.